request Request a Protocol
ask Ask a question
Favorite

Oleanolic acid (1, 2.1 g, 4.5 mmol) and DMAP (54 mg, 0.42 mmol) were dissolved in anhydrous THF (40 mL) under nitrogen. Diisopropylethylamine (DIPEA, 1.14 mL, 6.54 mmol) was added followed by dropwise addition of chloroacetyl chloride (0.96 mL, 12.1 mmol). After stirring for 2 h, absolute ethanol (1.5 mL) was used to quench the reaction. The solvent was removed in vacuo and the resulting crude product was adsorbed onto silica gel, after dissolving in CH2Cl2 (20 mL), then purified by column chromatography to obtain the desired chloroacetate as a white solid 2 (2.13 g, 87%). 1H-NMR (400 MHz, CDCl3) δ 5.24 (t, J = 3.4 Hz, 1H), 4.69–4.50 (m, 1H), 4.12 (s, 1H), 4.05 (d, J = 2.4 Hz, 2H), 2.24–1.18 (m, 24H), 1.08 (s, 3H), 1.00–0.93 (m, 7H), 0.89 (s, 3H), 0.86 (d, J = 7.9 Hz, 6H), 0.77 (s, 3H). 13C-NMR (100 MHz, CDCl3) δ 183.7, 167.3, 138.1, 125.9, 83.5, 55.4, 52.7, 48.1, 47.6, 42.1, 41.4, 39.6, 39.2, 39.0, 38.3, 38.1, 37.0, 36.8, 33.0, 33.0, 30.7, 28.2, 28.1, 24.2, 23.7, 23.6, 23.4, 21.3, 18.3, 17.1, 16.8, 15.7. HRMS (ESI) m/z for C32H48ClO4 ([M-H]) 531.3251, calc. 531.3247.

Chloroacetate 2 (2 g, 3.75 mmol) was dissolved in absolute ethanol (160 mL) along with NaI (1.82 g, 12.15 mmol) under nitrogen. After stirring at room temperature for 2 h, a solution of MeONH2 in THF (2.4 M, 1.9 mL, 4.56 mmol; made by stirring CH3ONH2·HCl in a NaOH/THF slurry for 24 h) was added, the nitrogen line removed, the reaction mixture was heated to 60 °C and stirred for 2 h, then the reaction was cooled to room temperature and another aliquot of MeONH2 in THF (2 eq.) was introduced followed by reheating to 60 °C. This additive process was repeated roughly every 2 h until the reaction had progressed sufficiently based upon TLC which occurred after ~24 h of total reaction time. The solvent was removed and the product purified by column chromatography (0.92 g, 45%). 1H-NMR (500 MHz, C5D5N) δ 5.49 (s, 1H), 4.93–4.63 (m, 1H), 3.92 (s, 2H), 3.63 (s, 3H), 3.32 (d, J = 11.3 Hz, 1H), 1.30 (s, 3H), 1.03 (s, 3H), 1.01 (s, 3H), 0.98 (s, 3H), 0.96 (s, 3H), 0.91 (s, 3H), 0.84 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 180.5, 171.6, 145.2, 122.7, 81.7, 61.8, 55.9, 54.2, 48.3, 47.0, 46.8, 42.5, 42.4, 40.1, 38.5, 38.4, 37.5, 34.6, 33.7, 33.6, 33.4, 31.4, 28.7, 28.5, 26.6, 24.3, 24.2, 24.2, 24.1, 18.9, 17.7, 17.3, 15.7. HRMS (ESI) m/z for C33H52NO5 ([M-H]) 542.3851, calc. 542.3851.

Oleanolic acid (1, 2.75 g, 5 mmol) was dissolved in anhydrous CH2Cl2 (200 mL), stirred and ice-bathed for 30 min. Then N,O-dimethylhydroxylamine hydrochloride (0.6 g, 6 mmol) and N-methylmorpholine (0.8 mL, 6 mmol) were added in order. The 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDAC, 1.5 g, 6.25 mmol) was slowly added over 10 min. After reacting in an ice-bath for 2 h, 5% HCl aqueous solution (50 mL) was added to quench the reaction. The acidic aqueous layer was extracted with CH2Cl2 (3 × 100 mL). The organic layers were combined and washed with saturated NaHCO3 solution and saturated NaCl solution, respectively. The organic layer was dried over anhydrous Na2SO4, then purified by column chromatography to obtain the desired white solid 5 (79%, 2.4 g). 1H-NMR (500 MHz, C5D5N) δ 5.43 (t, J = 3.4 Hz, 1H), 3.62 (s, 3H), 3.44 (d, J = 6.1 Hz, 1H), 3.34 (dd, J = 13.7, 3.9 Hz, 1H), 3.20 (s, 3H), 1.26 (s, 3H), 1.25 (s, 3H), 1.04 (s, 3H), 0.96 (s, 3H), 0.93 (s, 9H). 13C-NMR (125 MHz, C5D5N) δ 178.4, 145.3, 122.4, 78.2, 60.4, 56.0, 48.3, 48.1, 46.8, 42.5, 42.3, 39.7, 39.5, 39.0, 37.5, 34.4, 34.2, 33.3, 33.3, 30.8, 29.6, 28.9, 28.6, 28.2, 26.4, 23.9, 23.9, 22.5,18.9, 17.4, 16.6, 15.7. HRMS (ESI) m/z for C32H54NO3 ([M+H]+) 500.4090, calc. 500.4098.

Lithium aluminium hydride (LAH, 0.6 g, 5 eq) was dissolved in anhydrous THF (100 mL) under nitrogen. After in an ice-bath under nitrogen for 30 min, a solution of compound 5 in THF (1.5 g, dissolved in 30 mL anhydrous THF) was added dropwise. After another 30 min of ice-bath reaction, the reaction continued at room temperature for 4 h. The reaction was quenched with saturated NH4Cl solution, and the aqueous layer extracted with EtOAc (3 × 100 mL). The combined organic layer was washed with saturated NaCl solution, and then was dried over anhydrous Na2SO4. The crude product was redissolved with MeOH/CH2Cl2 (4:1, 150 mL), followed by addition of methoxyamino hydrochloride (CH3ONH2·HCl, 5 eq.) and pyridine (5 eq.), respectively. The reaction was heated to 55 °C under reflux for 8 h. Then purified by column chromatography to obtain the desired compound as a white solid 6 (81%, 1.1 g). 1H-NMR (500 MHz, C5D5N) δ 5.30 (t, J = 3.5 Hz, 1H), 3.92 (s, 3H), 3.48–3.40 (m, 1H), 2.52 (dd, J = 13.6, 4.0 Hz, 1H), 1.25 (s, 3H), 1.21 (s, 3H), 1.05 (s, 3H), 0.97 (s, 3H), 0.96 (s, 3H), 0.90 (s, 3H), 0.89 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 158.7, 144.4, 123.4, 78.3, 61.4, 56.0, 48.3, 46.3, 44.4, 42.1, 40.4, 39.9, 39.6, 39.2, 37.5, 34.2, 33.4, 33.3, 33.3, 31.0, 29.0, 28.3, 27.2, 26.5, 24.9, 24.0, 23.8, 19.0, 17.7, 16.8, 15.8. HRMS (ESI) m/z for C31H52NO2 ([M+H]+) 470.3991, calc. 470.3993.

Compound 6 (1 g, 2.1 mmol) was dissolved in acetic acid (100 mL), NaCNBH3 (10 eq.) was added. The reaction was stirred at room temperature for 10 h. Quench the reaction by adding saturated NaHCO3 solution (100 mL), and then was extracted with CH2Cl2 (3 × 100 mL). The organic layer was washed with saturated NaHCO3 solution, saturated NaCl solution, and was dried over anhydrous Na2SO4. Filtered, and the solvent was condensed under reduced pressure. The crude product was purified by column chromatography with PE/EtOAc (10: 1) to obtain desired product as a white solid 7 (83%, 0.83 g). 1H-NMR (500 MHz, C5D5N) δ 5.25 (t, J = 3.4 Hz, 1H), 3.63 (s, 3H), 3.43 (d, J = 9.0 Hz, 1H), 3.25 (dd, J = 11.7, 8.5 Hz, 1H), 2.77 (dd, J = 11.8, 6.8 Hz, 1H), 2.17 (dd, J = 13.5, 3.8 Hz, 1H), 1.24 (s, 3H), 1.23 (s, 3H), 1.04 (s, 3H), 1.01 (s, 3H), 0.94 (s, 3H), 0.91 (s, 3H), 0.90 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 145.0, 122.9, 78.2, 61.3, 59.9, 55.9, 48.2, 46.8, 45.2, 42.0, 40.4, 39.6, 39.3, 37.4, 36.1, 34.7, 33.6, 33.2, 33.1, 31.3, 28.9, 28.3, 26.4, 26.3, 24.1, 23.9, 23.5, 19.0, 17.2, 16.8, 16.0. HRMS (ESI) m/z for C31H54NO2 ([M+H]+) 472.4142, calc. 472.4149.

To a solution of neoaglycone 3 (typically 0.1 mmol, 54.2 mg) and reducing sugar (2 eq.) were dissolved in MeOH/CHCl3 (6:1, 5 mL). Neoaglycon 7 (0.1 mmol, 47.2 mg) and reducing sugar (2 eq.) was dissolved in MeOH/CHCl3 (4:1, 5 mL), external proton source AcOH (10 eq.) were added, and then reaction at 40 °C for 48 h on a rotary shaker at 250 rpm. The target neoglycosides was purified with MeOH/CH2Cl2 by silica gel column chromatography. The configuration of the glycosidic bond of all the neoglycosides was identified by the J value of JH1′H2′.

(3S)-O-(N-Methoxy-N-d-glucosylglycyl) oleanolic acid (4a)

White solid (15.2 mg, 21%). 1H-NMR (500 MHz, C5D5N) δ 5.50 (t, J = 3.3 Hz, 1H), 4.86–4.77 (m, 2H), 4.58 (dd, J = 11.9, 2.2 Hz, 1H), 4.43–4.33 (m, 2H), 4.32–4.19 (m, 3H), 4.15 (d, J = 16.9 Hz, 1H), 4.05 (s, 3H), 4.00–3.94 (m, 1H), 3.33 (dd, J = 13.8, 4.0 Hz, 1H), 1.31 (s, 3H), 1.04 (s, 3H), 1.01 (s, 3H), 0.98 (s, 3H), 0.89 (s, 3H), 0.84 (s, 3H), 0.82 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 180.5, 170.7, 145.2, 122.8, 95.6, 81.4, 80.8, 80.2, 72.1, 71.9, 63.3, 62.8, 55.9, 55.7, 48.3, 47.0, 46.8, 42.5, 42.4, 40.1, 38.6, 38.3, 37.5, 34.6, 33.6, 33.6, 33.4, 31.3, 28.7, 28.5, 26.6, 24.3, 24.1, 24.1, 24.1, 18.8, 17.7, 17.3, 15.8. HRMS (ESI) m/z for C39H64NO10 ([M+H]+) 706.4525, calc. 706.4525.

(3S)-O-(N-Methoxy-N-β-l-glucosylglycyl) oleanolic acid (4b)

White solid (11.0 mg, 16%). 1H-NMR (500 MHz, C5D5N) δ 5.50 (t, J = 3.1 Hz, 1H), 4.84 (d, J = 8.7 Hz, 1H), 4.81 (dd, J = 11.2, 5.4 Hz, 1H), 4.57 (dd, J = 11.8, 2.1 Hz, 1H), 4.40 (dd, J = 11.9, 5.4 Hz, 1H), 4.35–4.12 (m, 5H), 4.05 (s, 3H), 4.00–3.93 (m, 1H), 3.33 (dd, J = 13.7, 3.9 Hz, 1H), 1.30 (s, 3H), 1.04 (s, 3H), 1.01 (s, 3H), 0.98 (s, 3H), 0.92 (s, 3H), 0.84 (s, 3H), 0.83 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 180.0, 170.2, 144.7, 122.2, 94.9, 80.8, 80.2, 79.6, 71.6, 71.3, 62.7, 62.1, 55.3, 54.9, 47.7, 46.5, 46.3, 42.0, 41.8, 39.5, 38.0, 37.8, 37.0, 33.8, 33.1, 33.0, 32.8, 31.3, 28.1, 27.9, 26.0, 23.7, 23.6, 23.5, 22.7, 18.3, 17.2, 16.6, 15.2. HRMS (ESI) m/z for C39H64NO10 ([M+H]+) 706.4533, calc. 706.4525.

(3S)-O-(N-Methoxy-N-(2-deoxy-d-glucosyl)glycyl) oleanolic acid (4c)

White solid (38.5 mg, 56%). 1H-NMR (500 MHz, C5D5N) δ 5.49 (s, 1H), 4.83–4.77 (m, 2H), 4.55 (dd, J = 11.8, 2.3 Hz, 1H), 4.45–3.99 (m, 5H), 3.88 (s, 3H), 3.86–3.82 (m, 1H), 3.32 (dd, J = 13.7, 3.8 Hz, 1H), 2.71–2.54 (m, 1H), 1.30 (s, 3H), 1.03 (s, 3H), 1.01 (s, 3H), 0.98 (s, 3H), 0.92 (s, 3H), 0.85 (d, J = 4.0 Hz, 6H). 13C-NMR (125 MHz, C5D5N) δ 179.9, 170.0, 144.7, 122.2, 91.0, 80.9, 80.3, 73.2, 73.0, 62.8, 62.4, 55.5, 55.3, 47.7, 46.5, 46.3, 42.0, 41.8, 39.5, 38.0, 37.8, 37.5, 37.0, 34.0, 33.1, 33.0, 32.8, 30.8, 28.1, 27.9, 26.0, 23.7, 23.6, 23.6, 23.5, 18.3, 17.2, 16.8, 15.2. HRMS (ESI) m/z for C39H64NO9 ([M+H]+) 690.4575, calc. 690.4576.

(3S)-O-(N-Methoxy-N-(3-O-methyl-d-glucosyl)glycyl) oleanolic acid (4d)

White solid (10.7 mg, 15%). 1H-NMR (500 MHz, C5D5N) δ 5.48 (s, 1H), 4.89–4.70 (m, 2H), 4.56–4.29 (m, 5H), 4.26–4.05 (m, 2H), 4.02 (s, 3H), 3.96 (s, 3H), 3.93–3.84 (m, 1H), 3.32 (d, J = 13.2 Hz, 1H), 1.30 (s, 3H), 1.02 (d, J = 9.6 Hz, 3H), 1.00 (d, J = 4.8 Hz, 3H), 0.98 (d, J = 2.4 Hz, 3H), 0.88 (s, 3H), 0.84 (s, 3H), 0.82 (d, J = 3.8 Hz, 3H). 13C-NMR (125 MHz, C5D5N) δ 180.5, 168.2, 145.2, 122.7, 95.5, 82.0, 81.5, 80.6, 71.7, 71.1, 66.0, 63.0, 62.7, 55.9, 55.8, 48.3, 47.0, 46.8, 42.5, 42.3, 40.1, 38.5, 38.3, 37.5, 34.6, 33.6, 33.6, 33.4, 31.2, 28.7, 28.5, 26.5, 24.3, 24.1, 24.0, 23.3, 19.8, 17.7, 17.3, 14.1. HRMS (ESI) m/z for C40H66NO10 ([M+H]+) 720.4678, calc. 720.4681.

(3S)-O-(N-Methoxy-N-d-galactosylglycyl) oleanolic acid (4e)

White solid (16.1 mg, 23%). 1H-NMR (500 MHz, C5D5N) δ 5.50 (d, J = 11.1 Hz, 1H), 5.34 (d, J = 5.7 Hz, 0.67H, αH1′), 4.87–4.81 (m, 0.67H), 4.78 (dd, J = 10.4, 5.7 Hz, 1H), 4.63–4.43 (m, 2H), 4.42–4.13 (m, 4H), 3.99 (s, 3H), 3.95–3.89 (m, 1H), 3.44–3.25 (m, 1H), 1.30 (s, 3H), 1.03 (s, 3H), 1.01 (s, 3H), 0.98 (s, 3H), 0.83 (d, J = 2.0 Hz, 3H), 0.80 (s, 3H), 0.78 (d, J = 7.4 Hz, 3H). 13C-NMR (125 MHz, C5D5N) δ 179.9, 170.1, 144.6, 122.2, 99.8, 95.3, 84.0, 81.0, 80.8, 78.7, 78.6, 77.5, 76.3, 74.1, 72.6, 69.0, 65.3, 64.3, 55.3, 54.5, 47.7, 46.5, 46.3, 42.0, 41.8, 39.5, 38.0, 37.7, 37.0, 34.0, 33.1, 33.0, 32.8, 30.6, 28.1, 27.9, 26.0, 23.7, 23.6, 23.5, 23.5, 19.1, 17.2, 15.2, 13.5. HRMS (ESI) m/z for C39H64NO10 ([M+H]+) 706.4520, calc. 706.4525.

(3S)-O-(N-Methoxy-N-β-(2-deoxy-d-galactosyl)glycyl) oleanolic acid (4f)

White solid (29.8 mg, 43%). 1H-NMR (500 MHz, C5D5N) δ 5.49 (s, 1H), 4.79 (dd, J = 12.2, 5.2 Hz, 1H), 4.76 (d, J = 10.9 Hz, 1H), 4.52–4.01 (m, 6H), 3.99–3.90 (m, 1H), 3.85 (s, 3H), 3.33 (dd, J = 13.7, 3.7 Hz, 1H), 1.30 (s, 20H), 1.04 (s, 3H), 1.01 (s, 3H), 0.98 (s, 3H), 0.90 (s, 3H), 0.85 (s, 6H). 13C-NMR (125 MHz, C5D5N) δ 180.0, 170.1, 144.7, 122.2, 91.2, 80.9, 78.8, 70.2, 68.6, 62.5, 62.1, 55.3, 55.1, 47.7, 46.5, 46.3, 42.0, 41.8, 39.5, 38.0, 37.8, 37.0, 34.0, 33.1, 33.1, 33.0, 32.83, 30.18, 28.1, 27.9, 26.0, 23.7, 23.6, 23.5, 22.7, 18.3, 17.2, 16.8, 15.2. HRMS (ESI) m/z for C39H64NO9 ([M+H]+) 690.4581, calc. 690.4576.

(3S)-O-(N-Methoxy-N-d-mannosylglycyl) oleanolic acid (4g)

White solid (17.2 mg, 24%). 1H-NMR (500 MHz, C5D5N) δ 5.50 (d, J = 12.8 Hz, 1H), 5.13 (dd, J = 38.5, 21.1 Hz, 2H), 4.93 (d, J = 1.7 Hz, 0.5H, αH1′), 4.82–4.54 (m, 3H), 4.53–4.28 (m, 3H), 4.25–4.18 (m, 0.5H), 3.96 (s, 3H), 3.79 (s, 1H), 3.44–3.25 (m, 1H), 1.03 (s, 3H), 1.00 (d, J = 1.6 Hz, 3H), 0.98 (s, 3H), 0.84 (d, J = 7.0 Hz, 3H), 0.82 (d, J = 2.8 Hz, 3H), 0.78 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 180.0, 170.1, 144.6, 122.2, 93.7, 92.1, 81.0, 81.0, 80.5, 77.9, 76.2, 74.1, 73.2, 72.2, 68.8, 65.3, 64.3, 55.6, 55.3, 55.3, 47.7, 46.5, 46.3, 42.0, 41.8, 39.5, 38.0, 37.7, 34.0, 34.0, 33.1, 33.0, 32.8, 30.6, 28.1, 27.9, 26.0, 23.8, 23.6, 23.5, 23.5, 19.1, 17.2, 15.2, 13.5. HRMS (ESI) m/z for C39H64NO10 ([M+H]+) 706.4528, calc. 706.4525.

(3S)-O-(N-Methoxy-N-α-d-arabinosylglycyl) oleanolic acid (4h)

White solid (35.5 mg, 53%). 1H-NMR (500 MHz, C5D5N) δ 5.49 (s, 1H), 5.33 (d, J = 5.4 Hz, 1H), 4.81 (dd, J = 11.6, 4.7 Hz, 2H), 4.70–4.64 (m, 1H), 4.46–4.09 (m, 4H), 4.03–3.94 (m, 1H), 3.92 (s, 3H), 3.37–3.27 (m, 1H), 1.30 (d, J = 1.9 Hz, 3H), 1.03 (s, 3H), 1.01 (s, 3H), 0.98 (s, 3H), 0.93 (d, J = 4.0 Hz, 3H), 0.89 (s, 3H), 0.84 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 180.5, 170.5, 145.2, 122.8, 100.3, 85.7, 81.6, 79.4, 77.7, 63.1, 62.7, 55.9, 48.3, 47.0, 46.8, 42.5, 42.4, 40.1, 38.6, 38.4, 37.5, 34.6, 33.6, 33.6, 33.4, 31.9, 31.3, 30.7, 28.7, 28.5, 26.6, 24.3, 24.1, 24.1, 18.8, 17.7, 17.4, 15.7. HRMS (ESI) m/z for C38H62NO9 ([M+H]+) 676.4413, calc. 676.4419.

(3S)-O-(N-Methoxy-N-l-arabinosylglycyl) oleanolic acid (4i)

White solid (13.7 mg, 20%). 1H-NMR (500 MHz, C5D5N) δ 5.50 (s, 1H), 5.32 (d, J = 5.4 Hz, 0.5H, αH1′), 4.86–4.72 (m, 2H), 4.70–4.66 (m, 0.5H), 4.64 (d, J = 9.0 Hz, 0.5H, βH1′), 4.52 (t, J = 8.9 Hz, 0.5H), 4.42–4.26 (m, 2H), 4.19 (ddd, J = 29.1, 11.0, 5.8 Hz, 2H), 3.96 (d, J = 32.9 Hz, 3H), 3.33 (dd, J = 13.8, 3.7 Hz, 1H), 1.30 (s, 3H), 1.04 (s, 3H), 1.01 (s, 3H), 0.98 (s, 3H), 0.88 (s, 3H), 0.86 (d, J = 5.8 Hz, 3H), 0.83 (d, J = 4.6 Hz, 3H). 13C-NMR (125 MHz, C5D5N) δ 179.9, 170.2, 144.7, 122.2, 99.8, 95.5, 85.1, 81.0, 80.9, 78.9, 77.2, 75.6, 69.8, 69.1, 62.4, 62.2, 61.7, 55.6, 55.3, 47.7, 46.5, 46.3, 42.0, 41.8, 39.5, 37.8, 37.7, 37.0, 34.0, 33.1, 33.0, 32.8, 30.8, 28.1, 27.9, 26.0, 23.7, 23.6, 23.5, 18.3, 17.2, 16.8, 15.2. HRMS (ESI) m/z for C38H62NO9 ([M+H]+) 676.4411, calc. 676.4419.

(3S)-O-(N-Methoxy-N-d-fucosylglycyl) oleanolic acid (4j)

White solid (19.4 mg, 28%). 1H-NMR (500 MHz, C5D5N) δ 5.49 (s, 1H), 5.29 (d, J = 5.3 Hz, 0.67H, αH1′), 4.70 (d, J = 9.1 Hz, 0.33H, βH1′), 4.53–4.09 (m, 3H), 3.99 (s, 3H), 3.93 (s, 3H), 3.85 (dd, J = 12.7, 6.1 Hz, 0.5H), 3.70–3.60 (m, 0.5H), 3.32 (d, J = 13.1 Hz, 1H), 1.30 (s, 3H), 1.03 (s, 3H), 1.01 (s, 3H), 0.98 (s, 3H), 0.92 (d, J = 9.7 Hz, 3H), 0.87 (s, 3H), 0.84 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 180.5, 170.5, 145.2, 122.7, 100.2, 95.6, 88.0, 81.6, 81.5, 79.6, 78.4, 76.9, 73.6, 68.0, 62.8, 62.2, 56.0, 55.9, 52.3, 48.3, 47.0, 46.8, 42.5, 42.3, 40.1, 38.6, 38.3, 37.5, 34.6, 33.6, 33.6, 33.4, 31.3, 28.7, 28.5, 26.6, 24.3, 24.1, 24.1, 18.8, 17.7, 17.4, 17.3, 15.7, 14.6. HRMS (ESI) m/z for C39H64NO9 ([M+H]+) 690.4585, calc. 690.4576.

(3S)-O-(N-Methoxy-N-l-fucosylglycyl) oleanolic acid (4k)

White solid (17.3 mg, 25%). 1H-NMR (500 MHz, C5D5N) δ 5.49 (s, 1H), 5.31 (d, J = 5.3 Hz, 0.67H, αH1′), 4.72 (d, J = 9.0 Hz, 0.33H, βH1′), 4.49–4.04 (m, 3H), 3.99 (s, 3H), 3.93 (s, 3H), 3.86 (q, J = 6.4 Hz, 0.5H), 3.64 (dd, J = 9.3, 5.1 Hz, 0.5H), 3.32 (d, J = 13.6 Hz, 1H), 1.30 (s, 3H), 1.03 (s, 3H), 1.01 (s, 3H), 0.98 (s, 3H), 0.94–0.91 (m, 3H), 0.88 (s, 3H), 0.84 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 180.0, 170.0, 144.7, 122.2, 99.6, 95.0, 87.5, 81.0, 80.8, 79.0, 77.8, 76.3, 73.0, 67.4, 62.2, 61.6, 56.1, 55.3, 47.7, 46.5, 46.3, 42.0, 41.8, 39.5, 38.0, 37.8, 37.0, 34.0, 33.1, 33.0, 32.8, 30.8, 28.1, 27.9, 26.0, 23.7, 23.6, 23.5, 22.7, 18.3, 17.2, 16.8, 16.7, 15.2, 14.1. HRMS (ESI) m/z for C39H62NO9 ([M+H]) 688.4434, calc. 688.4430.

(3S)-O-(N-Methoxy-N-β-d-xylosylglycyl) oleanolic acid (4l)

White solid (15.0 mg, 22%). 1H-NMR (500 MHz, C5D5N) δ 5.49 (s, 1H), 4.70 (d, J = 8.4 Hz, 1H), 4.53–4.29 (m, 2H), 4.27–4.12 (m, 2H), 4.04 (s, 3H), 3.77–3.58 (m, 1H), 3.32 (d, J = 13.3 Hz, 1H), 1.30 (s, 3H), 1.03 (s, 3H), 1.00 (s, 3H), 0.98 (s, 3H), 0.91 (s, 3H), 0.89 (s, 3H), 0.83 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 180.7, 170.7, 145.2, 123.4, 96.2, 81.6, 80.3, 72.0, 71.3, 69.6, 62.7, 55.9, 55.6, 48.3, 47.0, 46.9, 42.5, 42.4, 40.1, 38.6, 38.4, 37.5, 34.6, 33.7, 33.6, 33.4, 30.8, 28.7, 28.5, 26.6, 24.3, 24.2, 24.1, 23.3, 18.8, 17.7, 17.3, 15.7. HRMS (ESI) m/z for C38H62NO9 ([M+H]+) 676.4426, calc. 676.4419.

(3S)-O-(N-Methoxy-N-β-l-xylosylglycyl) oleanolic acid (4m)

White solid (8.6 mg, 13%). 1H-NMR (500 MHz, C5D5N) δ 5.49 (s, 1H), 4.72 (d, J = 8.2 Hz, 1H), 4.58–4.36 (m, 2H), 4.34–4.13 (m, 3H), 4.04 (s, 3H), 3.32 (d, J = 13.6 Hz, 1H), 1.30 (s, 3H), 1.03 (s, 3H), 1.00 (s, 3H), 0.98 (s, 3H), 0.94 (s, 3H), 0.90 (s, 3H), 0.84 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 179.8, 170.2, 144.5, 122.9, 95.6, 80.9, 79.7, 71.4, 70.7, 69.0, 62.0, 55.3, 54.8, 47.7, 46.5, 46.3, 42.0, 41.8, 39.5, 38.0, 37.8, 37.0, 34.0, 33.1, 33.0, 32.8, 30.2, 28.1, 27.9, 26.0, 23.7, 23.6, 23.5, 22.7, 18.3, 17.2, 16.8, 15.2. HRMS (ESI) m/z for C38H62NO9 ([M+H]+) 676.4430, calc. 676.4419.

(3S)-O-(N-Methoxy-N-β-l-lyxosylglycyl) oleanolic acid (4n)

White solid (40.2 mg, 59%). 1H-NMR (500 MHz, C5D5N) δ 5.49 (t, J = 3.3 Hz, 1H), 5.18 (d, J = 8.2 Hz, 1H), 4.87–4.72 (m, 3H), 4.44–4.08 (m, 4H), 3.98 (s, 3H), 3.32 (dd, J = 13.9, 3.7 Hz, 1H), 1.30 (s, 3H), 1.03 (s, 3H), 1.01 (s, 3H), 0.98 (s, 3H), 0.91 (s, 3H), 0.88 (s, 3H), 0.84 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 179.9, 170.2, 144.6, 122.2, 92.2, 81.0, 72.9, 70.5, 67.6, 66.9, 61.8, 55.3, 55.1, 47.7, 46.5, 46.3, 42.0, 41.8, 39.5, 38.0, 37.8, 37.0, 34.0, 33.1, 33.0, 32.8, 30.8, 28.1, 27.9, 26.0, 23.7, 23.6, 23.6, 23.5, 18.3, 17.2, 16.8, 15.2. HRMS (ESI) m/z for C38H62NO9 ([M+H]+) 676.4417, calc. 676.4419.

(3S)-O-(N-Methoxy-N-l-rhamnosylglycyl) oleanolic acid (4o)

White solid (16.4 mg, 24%). 1H-NMR (500 MHz, C5D5N) δ 5.49 (s, 1H), 5.14-5.09 (m, 0.8H), 4.99 (s, 0.2H), 4.88 (s, 0.5H), 4.85–4.76 (m, 0.8H), 4.67 (d, J = 2.0 Hz, 0.2H, αH1′), 4.61 (dd, J = 8.8, 3.3 Hz, 0.5H), 4.47–4.38 (m, 0.6H), 4.38–4.24 (m, 1H), 4.20–4.08 (m, 0.4H), 3.97–3.77 (m, 2H), 3.74 (s, 3H), 3.31 (d, J = 13.2 Hz, 1H), 1.30 (s, 3H), 1.03 (s, 3H), 1.00 (d, J = 3.7 Hz, 3H), 0.97 (s, 3H), 0.95 (d, J = 6.6 Hz, 3H), 0.93 (s, 3H), 0.87 (dd, J = 10.8, 5.1 Hz, 3H), 0.82 (d, J = 10.4 Hz, 3H). 13C-NMR (125 MHz, C5D5N) δ 180.5, 170.4, 145.2, 122.7, 94.4, 92.4, 81.7, 81.1, 74.3, 74.0, 73.5, 72.9, 72.7, 70.4, 62.4, 61.8, 56.7, 55.9, 48.2, 47.0, 46.8, 42.5, 42.3, 40.1, 38.5, 38.3, 37.5, 34.6, 33.6, 33.6, 33.4, 31.3, 28.7, 28.6, 26.6, 24.3, 24.1, 24.1, 24.1, 19.2, 17.7, 17.4, 17.4, 15.7, 14.6. HRMS (ESI) m/z for C39H64NO9 ([M+H]+) 690.4578, calc. 690.4576.

(3S)-O-(N-Methoxy-N-d-ribosylglycyl) oleanolic acid (4p)

White solid (42.1 mg, 62%). 1H-NMR (500 MHz, C5D5N) δ 5.49 (s, 1H), 5.41 (d, J = 2.9 Hz, 0.33H, αH1′), 5.08 (d, J = 8.2 Hz, 0.67H, βH1′), 4.86–4.72 (m, 2H), 4.67 (d, J = 4.9 Hz, 1H), 4.41–4.06 (m, 4H), 4.05 (s, 3H), 3.91 (d, J = 15.8 Hz, 1H), 3.32 (d, J = 12.9 Hz, 1H), 1.30 (s, 3H), 1.03 (s, 3H), 1.01 (s, 3H), 0.98 (s, 3H), 0.94 (s, 3H), 0.91 (s, 3H), 0.83 (d, J = 4.4 Hz, 3H). 13C-NMR (125 MHz, C5D5N) δ 180.3, 170.5, 145.0, 122.6, 100.7, 92.0, 85.6, 81.3, 73.2, 72.7, 72.5, 69.2, 68.8, 66.4, 63.9, 62.6, 62.5, 55.7, 48.1, 46.8, 46.6, 42.3, 42.2, 39.9, 38.4, 38.1, 37.3, 34.4, 33.4, 33.4, 33.2, 31.1, 28.5, 28.3, 26.4, 24.1, 23.9, 23.9, 23.9, 18.6, 17.5, 17.1, 15.5. HRMS (ESI) m/z for C38H62NO9 ([M+H]+) 676.4423, calc. 676.4419.

(3S)-O-(N-Methoxy-N-l-ribosylglycyl) oleanolic acid (4q)

White solid (40.8 mg, 60%). 1H-NMR (500 MHz, C5D5N) δ 5.49 (s, 1H), 5.42 (d, J = 3.7 Hz, 0.33H, αH1′), 5.10 (d, J = 8.6 Hz, 0.67H, βH1′), 4.86–4.70 (m, 2H), 4.67 (dd, J = 9.3, 4.7 Hz, 1H), 4.35–4.16 (m, 4H), 4.04 (s, 3H), 3.95 (s, 0.33H), 3.89 (s, 0.67H), 3.32 (d, J = 13.6 Hz, 1H), 1.30 (d, J = 2.8 Hz, 3H), 1.03 (s, 3H), 1.01 (s, 3H), 0.98 (s, 3H), 0.94 (s, 3H), 0.91 (d, J = 6.1 Hz, 3H), 0.83 (d, J = 4.6 Hz, 3H). 13C-NMR (125 MHz, C5D5N) δ 180.5, 170.8, 145.2, 122.8, 100.9, 92.2, 85.8, 81.5, 73.4, 72.9, 72.7, 69.5, 69.0, 66.6, 64.0, 62.8, 62.7, 55.9, 48.3, 47.0, 46.8, 42.5, 42.4, 40.1, 38.6, 38.4, 37.5, 34.6, 33.6, 33.6, 33.4, 31.3, 28.7, 28.5, 26.6, 24.3, 24.1, 24.1, 24.1, 18.8, 17.7, 17.3, 15.7. HRMS (ESI) m/z for C38H62NO9 ([M+H]+) 676.4413, calc. 676.4419.

(3S)-O-(N-Methoxy-N-(2-deoxy-d-ribosyl)glycyl) oleanolic acid (4r)

White solid (32.5 mg, 49%). 1H-NMR (500 MHz, C5D5N) δ 5.49 (s, 1H), 5.32 (d, J = 2.9 Hz, 0.8H, αH1′), 4.73–4.46 (m, 2H), 4.24–4.05 (m, 4H), 3.86 (s, 3H), 3.50 (d, J = 10.1 Hz, 1H), 3.35–3.29 (m, 1H), 1.30 (s, 3H), 1.03 (s, 3H), 1.01 (s, 3H), 0.98 (s, 3H), 0.93 (d, J = 7.5 Hz, 3H), 0.88 (d, J = 10.6 Hz, 3H), 0.84 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 180.5, 168.2, 145.2, 122.8, 106.2, 91.8, 82.3, 81.5, 72.5, 71.1, 70.8, 68.8, 68.6, 66.0, 63.3, 62.8, 62.5, 55.9, 48.3, 47.0, 46.8, 42.5, 42.4, 40.1, 38.6, 38.4, 37.5, 34.6, 33.6, 33.6, 33.4, 31.2, 28.7, 28.5, 26.6, 24.3, 24.2, 24.2, 24.1, 18.9, 17.7, 17.4, 15.8. HRMS (ESI) m/z for C38H60NO8 ([M+H]) 658.4326, calc. 658.4324.

28-N-Methoxyaminooleanane-β-d-glucoside (8a)

White solid (36.2 mg, 60%). 1H-NMR (500 MHz, C5D5N) δ 5.20 (d, J = 3.0 Hz, 1H), 4.61 (d, J = 7.9 Hz, 1H), 4.48 (dd, J = 11.8, 2.6 Hz, 1H), 4.36 (dd, J = 11.8, 4.9 Hz, 1H), 4.27–4.18 (m, 3H), 3.93–3.88 (m, 1H), 3.80 (s, 3H), 3.46–3.36 (m, 2H), 3.10 (d, J = 15.3 Hz, 1H), 2.27–2.09 (m, 1H), 1.21 (s, 3H), 1.20 (s, 3H), 1.05 (s, 3H), 1.02 (s, 3H), 0.89 (d, J = 1.3 Hz, 6H), 0.88 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 145.7, 123.7, 97.6, 81.1, 80.8, 78.8, 72.6, 72.5, 63.7, 56.5, 48.8, 48.0, 45.6, 42.6, 41.0, 40.2, 39.9, 38.0, 37.1, 35.6, 34.2, 33.7, 33.6, 32.3, 31.8, 31.1, 30.7, 29.5, 28.9, 27.2, 26.9, 24.8, 24.7, 19.6, 18.1, 17.3, 16.5. HRMS (ESI) m/z for C37H64NO7 ([M+H]+) 634.4676, calc. 634.4677.

28-N-Methoxyaminooleanane-β-l-glucoside (8b)

White solid (32.2 mg, 51%). 1H-NMR (500 MHz, C5D5N) δ 5.19 (d, J = 3.0 Hz, 1H), 4.60 (d, J = 8.0 Hz, 1H), 4.48 (dd, J = 11.8, 2.5 Hz, 1H), 4.37 (dd, J = 11.8, 4.9 Hz, 1H), 4.30–4.22 (m, 3H), 3.86 (s, 1H), 3.81 (s, 3H), 3.44–3.38 (m, 2H), 3.22 (d, J = 14.9 Hz, 1H), 2.26–2.18 (m, 1H), 1.23 (s, 3H), 1.20 (s, 3H), 1.09 (s, 3H), 1.02 (s, 3H), 0.95 (s, 3H), 0.90 (s, 3H), 0.86 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 145.1, 123.0, 97.2, 80.5, 80.3, 78.2, 72.2, 71.9, 63.0, 55.9, 48.1, 47.4, 44.5, 42.0, 40.4, 39.5, 39.2, 37.3, 36.7, 35.0, 33.5, 33.2, 33.1, 31.6, 31.2, 30.5, 30.1, 28.9, 28.2, 26.4, 26.1, 24.0, 23.9, 18.9, 17.7, 16.7, 15.9. HRMS (ESI) m/z for C37H64NO7 ([M+H]+) 634.4673, calc. 634.4677.

28-N-Methoxyaminooleanane-β-2-deoxy-d-glucoside (8c)

White solid (33.9 mg, 53%). 1H-NMR (500 MHz, C5D5N) δ 5.21 (t, J = 3.2 Hz, 1H), 4.72 (d, J = 10.5 Hz, 1H), 4.50 (dd, J = 11.6, 2.8 Hz, 1H), 4.39 (dd, J = 11.6, 4.9 Hz, 1H), 4.30–4.23 (m, 1H), 4.06 (t, J = 9.0 Hz, 1H), 3.86–3.80 (m, 1H), 3.66 (s, 3H), 3.44 (dd, J = 10.9, 4.8 Hz, 1H), 3.34 (d, J = 15.1 Hz, 1H), 2.96 (d, J = 15.2 Hz, 1H), 2.60–2.47 (m, 1H), 1.26 (s, 3H), 1.24 (s, 3H), 1.08 (s, 3H), 1.06 (s, 3H), 0.95 (s, 3H), 0.94 (s, 3H), 0.91 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 145.0, 123.2, 92.8, 80.5, 78.2, 73.9, 73.6, 63.3, 55.8, 48.2, 47.3, 45.0, 41.9, 40.4, 39.5, 39.2, 37.7, 37.3, 36.3, 34.9, 33.5, 33.0, 31.6, 31.1, 30.5, 30.1, 28.9, 28.2, 26.5, 26.1, 24.1, 24.0, 23.9, 18.9, 17.4, 16.6, 15.9. HRMS (ESI) m/z for C37H64NO6 ([M+H]+) 618.4730, calc. 618.4728.

28-N-Methoxyaminooleanane-β-3-O-methyl-d-glucoside (8d)

White solid (25.2 mg, 39%). 1H-NMR (500 MHz, C5D5N) δ 5.27 (s, 1H), 4.63 (d, J = 8.9 Hz, 1H), 4.50 (dd, J = 11.8, 2.5 Hz, 1H), 4.39 (dd, J = 11.8, 4.8 Hz, 1H), 4.23 (q, J = 9.1 Hz, 2H), 3.95 (s, 3H), 3.85–3.77 (m, 4H), 3.50–3.41 (m, 2H), 3.13 (d, J = 15.3 Hz, 1H), 2.32–2.18 (m, 1H), 1.27 (s, 3H), 1.27 (s, 3H), 1.11 (s, 3H), 1.09 (s, 3H), 0.96 (s, 3H), 0.95 (s, 3H), 0.95 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 144.9, 122.9, 96.6, 90.0, 80.1, 78.1, 71.2, 70.8, 62.6, 60.9, 55.7, 48.0, 47.2, 44.7, 41.8, 40.2, 39.4, 39.1, 37.2, 36.3, 34.8, 33.4, 32.8, 32.8, 31.5, 31.0, 30.3, 28.7, 28.1, 26.4, 26.1, 24.1, 23.9, 23.8, 18.8, 17.3, 16.5, 15.7. HRMS (ESI) m/z for C38H66NO7 ([M+H]+) 648.4825, calc. 648.4834.

28-N-Methoxyaminooleanane-d-galactoside (8e)

White solid (35.8 mg, 56%). 1H-NMR (500 MHz, C5D5N) δ 5.23 (t, J = 5.4 Hz, 1H), 5.11 (d, J = 6.2 Hz, 0.2H, βH1′), 4.67 (d, J = 2.8 Hz, 0.8H, αH1′), 4.62 (s, 1H), 4.56–4.46 (m, 1H), 4.43–4.33 (m, 2H), 4.24 (dt, J = 9.5, 4.7 Hz, 1H), 4.10 (t, J = 6.3 Hz, 1H), 3.83–3.78 (m, 3H), 3.70–3.60 (m, 1H), 3.45 (dd, J = 10.9, 5.1 Hz, 1H), 3.11 (dd, J = 15.2, 8.0 Hz, 1H), 1.28 (s, 3H), 1.25 (s, 3H), 1.14 (d, J = 6.5 Hz, 3H), 1.06 (s, 3H), 0.94 (s, 3H), 0.92 (s, 3H), 0.86 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 145.0, 122.8, 101.7, 97.1, 83.8, 78.7, 78.3, 78.2, 78.0, 76.9, 73.0, 70.2, 69.6, 64.9, 62.2, 61.6, 55.8, 48.2, 47.3, 45.4, 42.0, 40.4, 39.5, 39.2, 37.3, 36.5, 34.8, 33.5, 33.3, 33.0, 31.1, 30.5, 30.0, 28.8, 28.2, 26.5, 26.5, 26.2, 24.0, 18.9, 17.4, 16.6, 15.8. HRMS (ESI) m/z for C37H64NO7 ([M+H]+) 634.4676, calc. 634.4677.

28-N-Methoxyaminooleanane-2-deoxy-d-galactoside (8f)

White solid (33.1 mg, 54%). 1H-NMR (500 MHz, C5D5N) δ 5.36 (d, J = 6.5 Hz, 0.33H, αH1′), 5.15 (t, J = 3.3 Hz, 1H), 4.69–4.62 (m, 1H), 4.52–4.35 (m, 3H), 4.32–4.28 (m, 0.67 H), 3.95 (t, J = 6.1 Hz, 1H), 3.67 (d, J = 8.1 Hz, 3H), 3.52–3.42 (m, 3H), 2.95 (d, J = 15.3 Hz, 1H), 1.28–1.25 (m, 6H), 1.12 (s, 3H), 1.07 (s, 3H), 0.95 (s, 6H), 0.88 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 144.8, 122.7, 98.0, 97.0, 92.8, 86.8, 86.3, 78.8, 78.0, 73.7, 73.1, 72.1, 71.8, 70.7, 68.6, 65.0, 64.7, 62.3, 55.7, 48.0, 48.0, 47.2, 45.1, 41.8, 41.8, 40.2, 39.3, 39.0, 37.2, 36.2, 34.7, 30.9, 28.7, 28.0, 26.3, 25.9, 23.8, 23.7, 23.6, 18.7, 17.3, 16.4, 15.7. HRMS (ESI) m/z for C37H64NO6 ([M+H]+) 618.4739, calc. 618.4728.

28-N-Methoxyaminooleanane-d-mannoside (8g)

White solid (33.5 mg, 52%). 1H-NMR (500 MHz, C5D5N) δ 5.24 (t, J = 5.4 Hz, 1H), 5.00 (d, J = 2.5 Hz, 0.5H, αH1′), 4.77–4.70 (m, 0.5H), 4.67 (dt, J = 8.3, 4.0 Hz, 1H), 4.59–4.43 (m, 2H), 4.38–4.17 (m, 1H), 3.99–3.57 (m, 5H), 3.54–3.32 (m, 2H), 3.03 (dd, J = 20.5, 14.9 Hz, 1H), 1.28 (d, J = 3.1 Hz, 3H), 1.27 (d, J = 2.8 Hz, 3H), 1.07 (t, J = 3.1 Hz, 3H), 0.98 (t, J = 3.5 Hz, 3H), 0.95 (s, 3H), 0.93 (d, J = 2.8 Hz, 3H), 0.89 (d, J = 11.2 Hz, 3H). 13C-NMR (125 MHz, C5D5N) δ 145.0, 122.9, 102.6, 96.1, 93.8, 82.0, 81.3, 78.2, 77.1, 73.4, 72.5, 71.5, 69.8, 65.2, 63.5, 62.3, 60.6, 55.9, 48.2, 47.3, 45.2, 42.0, 40.3, 39.5, 39.2, 37.3, 36.6, 35.0, 33.5, 31.6, 31.1, 30.5, 28.9, 28.2, 26.6, 26.4, 24.1, 24.0, 23.9, 18.9, 17.5, 16.6, 15.9. HRMS (ESI) m/z for C37H64NO7 ([M+H]+) 634.4672, calc. 634.4677.

28-N-Methoxyaminooleanane-d-arabinoside (8h)

White solid (35.2 mg, 58%). 1H-NMR (500 MHz, C5D5N) δ 5.25 (t, J = 3.1 Hz, 1H), 5.18 (d, J = 5.5 Hz, 0.67H, αH1′), 4.67–4.63 (m, 1H), 4.61–4.50 (m, 1H), 4.46–4.34 (m, 2H), 4.29–4.21 (m, 1H), 4.16 (dd, J = 8.9, 3.4 Hz, 0.33H), 3.89–3.78 (m, 3H), 3.49–3.42 (m, 2H), 3.34 (dd, J = 50.9, 15.5 Hz, 1H), 2.28 (dd, J = 13.6, 3.8 Hz, 0.33H), 1.30 (s, 3H), 1.26 (d, J = 1.8 Hz, 3H), 1.08 (d, J = 2.8 Hz, 3H), 1.06 (s, 3H), 0.95 (d, J = 3.4 Hz, 3H), 0.93 (s, 3H), 0.90 (d, J = 5.7 Hz, 3H). 13C-NMR (125 MHz, C5D5N) δ 144.8, 122.7, 102.0, 97.6, 84.3, 78.0, 77.7, 76.3, 70.2, 69.5, 69.4, 62.7, 61.9, 55.7, 48.0, 47.2, 45.1, 41.9, 40.2, 39.3, 39.1, 37.2, 36.5, 34.8, 33.3, 33.1, 33.0, 31.4, 30.9, 30.3, 29.9, 28.7, 28.1, 26.3, 26.0, 23.9, 23.7, 18.7, 17.5, 16.5, 15.7. HRMS (ESI) m/z for C36H62NO6 ([M+H]+) 604.4581, calc. 604.4572.

28-N-Methoxyaminooleanane-l-arabinoside (8i)

White solid (37.3 mg, 62%). 1H-NMR (500 MHz, C5D5N) δ 5.18 (d, J = 5.9 Hz, 0.5H, αH1′), 5.14 (t, J = 3.2 Hz, 2H), 4.63–4.59 (m, 0.5H), 4.53–4.41 (m, 2H), 4.31–4.11 (m, 3H), 3.73 (d, J = 6.3 Hz, 3H), 3.42 (dd, J = 10.9, 4.9 Hz, 1H), 3.01 (d, J = 15.5 Hz, 1H), 2.17 (d, J = 10.6 Hz, 3H), 1.25 (s, 3H), 1.21 (s, 3H), 1.11 (s, 3H), 1.02 (s, 3H), 0.94 (s, 3H), 0.88 (s, 3H), 0.78 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 144.9, 122.6, 101.4, 97.0, 84.6, 78.1, 76.2, 70.2, 69.6, 69.5, 55.8, 55.7, 48.1, 48.1, 47.1, 45.6, 41.9, 41.9, 40.3, 40.2, 39.4, 39.1, 37.3, 36.4, 33.4, 33.0, 31.5, 31.0, 30.4, 30.0, 28.8, 28.1, 26.4, 26.1, 23.9, 23.9, 23.5, 18.8, 17.4, 16.5, 15.8. HRMS (ESI) m/z for C36H62NO6 ([M+H]+) 604.4576, calc. 604.4572.

28-N-Methoxyaminooleanane-d-fucoside (8j)

White solid (35.2 mg, 57%). 1H-NMR (500 MHz, C5D5N) δ 5.15 (s, 1H), 4.51 (dt, J = 17.5, 8.7 Hz, 2H), 4.18 (dd, J = 8.7, 3.4 Hz, 1H), 4.09 (d, J = 2.8 Hz, 1H), 3.88 (q, J = 6.0 Hz, 1H), 3.78 (s, 3H), 3.66 (t, J = 9.8 Hz, 1H), 3.47 (dd, J = 11.0, 4.9 Hz, 1H), 3.10–3.04 (m, 1H), 1.29 (s, 3H), 1.27 (s, 3H), 1.19 (s, 3H), 1.08 (s, 3H), 0.99 (s, 3H), 0.93 (s, 3H), 0.86 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 145.5, 123.3, 97.2, 87.6, 78.7, 77.4, 74.0, 73.5, 69.7, 56.4, 48.7, 47.8, 46.1, 42.5, 40.9, 40.0, 39.7, 37.9, 37.0, 35.3, 34.0, 33.9, 33.6, 32.1, 31.6, 31.0, 30.6, 29.4, 28.7, 27.0, 26.7, 24.5, 19.4, 18.1, 18.0, 17.1, 16.4. HRMS (ESI) m/z for C37H64NO6 ([M+H]+)618.4733, calc. 618.4728.

28-N-Methoxyaminooleanane-β-l-fucoside (8k)

White solid (38.9 mg, 63%). 1H-NMR (500 MHz, C5D5N) δ 5.19 (d, J = 3.2 Hz, 1H), 4.49 (t, J = 8.8 Hz, 1H), 4.44 (d, J = 8.7 Hz, 1H), 4.10 (dd, J = 8.8, 3.4 Hz, 1H), 4.04 (d, J = 2.9 Hz, 1H), 3.80 (d, J = 6.9 Hz, 1H), 3.74 (s, 3H), 3.42 (dd, J = 10.9, 4.9 Hz, 1H), 3.35 (dd, J = 14.9, 3.9 Hz, 1H), 3.26 (d, J = 15.0 Hz, 1H), 2.26 (dd, J = 13.4, 3.9 Hz, 1H), 1.25 (s, 3H), 1.22 (s, 3H), 1.14 (s, 3H), 1.02 (d, J = 2.3 Hz, 3H), 0.97 (s, 3H), 0.91 (s, 6H). 13C-NMR (125 MHz, C5D5N) δ 145.0, 122.7, 96.9, 86.6, 78.0, 76.9, 73.3, 72.8, 68.9, 55.7, 48.0, 47.3, 44.3, 41.9, 40.2, 39.3, 39.1, 37.2, 37.2, 36.4, 34.8, 33.3, 33.0, 32.8, 31.0, 28.7, 28.0, 26.2, 25.9, 23.9, 23.8, 20.5, 18.7, 17.4, 17.4, 16.5, 15.7. HRMS (ESI) m/z for C37H64NO6 ([M+H]+) 618.4732, calc. 618.4728.

28-N-Methoxyaminooleanane-β-d-xyloside (8l)

White solid (38.2 mg, 63%). 1H-NMR (500 MHz, C5D5N) δ 5.26 (t, J = 3.3 Hz, 1H), 4.57 (d, J = 6.7 Hz, 1H), 4.40 (dd, J = 10.8, 4.5 Hz, 1H), 4.19 (d, J = 13.9 Hz, 3H), 3.80 (s, 3H), 3.69 (t, J = 10.4 Hz, 1H), 3.52 (d, J = 15.3 Hz, 1H), 3.41 (t, J = 14.6 Hz, 1H), 3.03 (d, J = 15.4 Hz, 1H), 2.25–2.14 (m, 1H), 1.26 (s, 3H), 1.23 (s, 3H), 1.10 (s, 3H), 1.04 (s, 3H), 0.92 (s, 3H), 0.92 (s, 3H), 0.89 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 144.9, 122.7, 97.1, 80.1, 78.0, 71.7, 70.9, 69.2, 55.7, 48.0, 47.0, 45.3, 41.8, 40.2, 39.3, 39.0, 37.2, 36.2, 34.7, 33.3, 33.1, 32.8, 31.4, 31.0, 30.3, 28.7, 28.0, 26.3, 26.1, 23.8, 23.8, 23.6, 18.7, 17.2, 16.4, 15.7. HRMS (ESI) m/z for C36H62NO6 ([M+H]+) 604.4572, calc. 604.4572.

28-N-Methoxyaminooleanane-β-l-xyloside (8m)

White solid (37.2 mg, 62%). 1H-NMR (500 MHz, C5D5N) δ 5.30 (t, J = 3.2 Hz, 1H), 4.55 (d, J = 8.7 Hz, 1H), 4.43 (dd, J = 11.1, 5.2 Hz, 1H), 4.28–4.18 (m, 3H), 3.85 (s, 3H), 3.70 (t, J = 10.7 Hz, 1H), 3.49–3.43 (m, 1H), 3.34 (d, J = 5.8 Hz, 2H), 2.29 (dd, J = 13.3, 3.8 Hz, 1H), 1.29 (s, 3H), 1.25 (s, 3H), 1.17 (s, 3H), 1.06 (s, 3H), 0.99 (s, 3H), 0.95 (s, 3H), 0.92 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 145.0, 122.8, 97.8, 80.2, 78.1, 71.7, 71.1, 69.3, 55.7, 49.6, 48.0, 47.2, 44.7, 42.0, 40.3, 39.4, 39.1, 37.2, 36.5, 34.8, 33.4, 33.1, 33.0, 31.5, 31.0, 30.3, 28.7, 28.1, 26.3, 26.0, 23.9, 23.8, 18.8, 17.5, 16.5, 15.7. HRMS (ESI) m/z for C36H62NO6 ([M+H]+) 604.4578, calc. 604.4572.

28-N-Methoxyaminooleanane-l-lyxoside (8n)

White solid (34.2 mg, 57%). 1H-NMR (500 MHz, C5D5N) δ 5.88 (d, J = 3.5 Hz, 0.2H, αH1′), 5.22 (d, J = 3.2 Hz, 1H), 4.81 (d, J = 3.3 Hz, 1H), 4.78–4.72 (m, 1H), 4.72–4.65 (m, 0.8H), 4.49–4.42 (m, 1H), 4.35 (dd, J = 11.2, 4.2 Hz, 1H), 4.23 (dd, J = 18.4, 8.8 Hz, 1H), 3.97–3.78 (m, 3H), 3.60–3.43 (m, 2H), 3.09 (dd, J = 16.5, 15.1 Hz, 1H), 1.29–1.27 (m, 3H), 1.25 (d, J = 11.2 Hz, 3H), 1.16 (d, J = 5.4 Hz, 3H), 1.09–1.06 (m, 3H), 0.98 (d, J = 7.0 Hz, 3H), 0.95 (d, J = 3.8 Hz, 3H), 0.91 (d, J = 3.2 Hz, 3H). 13C-NMR (125 MHz, C5D5N) δ 145.56, 123.23, 102.50, 96.98, 83.26, 78.68, 73.85, 73.61, 73.41, 71.79, 69.99, 68.58, 67.66, 56.35, 50.22, 48.67, 47.71, 46.17, 42.49, 40.87, 39.97, 39.69, 37.83, 36.97, 35.39, 34.02, 33.98, 33.79, 33.52, 31.59, 30.94, 29.33, 28.70, 26.97, 26.73, 24.49, 24.43, 19.39, 17.92, 17.11, 16.34. HRMS (ESI) m/z for C36H62NO6 ([M+H]+) 604.4575, calc. 604.4572.

28-N-Methoxyaminooleanane-l-rhamnoside (8o)

White solid (34.7 mg, 56%). 1H-NMR (500 MHz, C5D5N) δ 5.33 (t, J = 3.3 Hz, 1H), 5.28 (d, J = 6.1 Hz, 0.2H, βH1′), 4.69 (d, J = 2.9 Hz, 0.8H, αH1′), 4.34–4.29 (m, 1H), 4.19 (t, J = 9.1 Hz, 1H), 4.07 (dd, J = 9.2, 3.0 Hz, 1H), 3.84 (d, J = 7.8 Hz, 3H), 3.76 (dq, J = 9.3, 6.1 Hz, 1H), 3.51–3.39 (m, 4H), 3.12 (d, J = 14.6 Hz, 1H), 1.18 (s, 3H), 1.08 (d, J = 3.1 Hz, 3H), 1.07 (s, 3H), 1.01 (s, 3H), 0.99 (s, 3H), 0.98 (s, 6H). 13C-NMR (125 MHz, C5D5N) δ 145.8, 123.2, 102.2, 95.3, 86.4, 78.7, 77.3, 76.9, 74.6, 72.5, 63.8, 62.3, 61.6, 56.4, 48.7, 48.0, 45.2, 42.5, 40.9, 40.0, 40.0, 39.7, 37.9, 37.1, 34.0, 32.1, 31.6, 31.6, 31.0, 30.6, 29.4, 29.3, 28.7, 27.0, 26.6, 24.5, 24.4, 19.4, 19.3, 18.3, 17.1, 17.1, 16.4. HRMS (ESI) m/z for C37H64NO6 ([M+H]+) 618.4733, calc. 618.4728.

28-N-Methoxyaminooleanane-d-riboside (8p)

White solid (34.9 mg, 58%). 1H-NMR (500 MHz, C5D5N) δ 5.29 (t, J = 3.0 Hz, 1H), 5.23 (d, J = 3.4 Hz, 0.5H, αH1′), 4.80–4.62 (m, 2H), 4.35 (dd, J = 11.6, 3.7 Hz, 0.5H), 4.31–4.14 (m, 3H), 3.91–3.77 (m, 3H), 3.50–3.34 (m, 2H), 3.04 (dd, J = 38.0, 15.1 Hz, 1H), 1.28 (d, J = 2.7 Hz, 3H), 1.27 (s, 3H), 1.08 (d, J = 2.6 Hz, 3H), 0.97 (dd, J = 12.2, 3.2 Hz, 6H), 0.95 (d, J = 4.4 Hz, 3H), 0.93 (d, J = 3.9 Hz, 3H). 13C-NMR (125 MHz, C5D5N) δ 145.3, 122.9, 103.6, 93.4, 84.7, 78.3, 73.0, 72.6, 69.3, 68.8, 66.4, 64.1, 62.2, 56.0, 55.9, 48.2, 47.3, 45.6, 42.1, 40.5, 39.6, 39.3, 37.4, 36.6, 33.6, 31.7, 31.3, 30.6, 29.0, 28.9, 28.3, 26.6, 26.5, 26.4, 24.1, 24.1, 24.0, 19.0, 17.4, 16.7, 15.9. HRMS (ESI) m/z for C36H62NO6 ([M+H]+) 604.4580, calc. 604.4572.

28-N-Methoxyaminooleanane-l-riboside (8q)

White solid (33.2 mg, 55%). 1H-NMR (500 MHz, C5D5N) δ 5.24 (t, J = 3.2 Hz, 1H), 5.20 (d, J = 3.1 Hz, 0.5H, αH1′), 4.81–4.60 (m, 2H), 4.38 (dd, J = 11.7, 3.6 Hz, 0.5H), 4.31–4.18 (m, 3H), 3.84 (s, 3H), 3.46 (dd, J = 10.8, 5.1 Hz, 1H), 3.33 (dd, J = 14.9, 8.7 Hz, 1H), 2.98 (d, J = 14.8 Hz, 1H), 1.26 (s, 3H), 1.17 (s, 3H), 1.07 (s, 3H), 1.03 (s, 3H), 0.95 (s, 3H), 0.94 (d, J = 2.3 Hz, 3H), 0.93 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 145.0, 123.0, 104.3, 94.0, 84.3, 78.3, 73.1, 72.7, 69.2, 68.9, 64.0, 62.5, 55.9, 48.3, 47.3, 45.2, 44.9, 42.2, 42.1, 40.6, 40.4, 39.6, 39.3, 37.4, 37.4, 36.8, 36.7, 35.0, 33.6, 33.6, 31.2, 28.9, 28.3, 26.5, 26.5, 26.3, 24.1, 24.0, 23.8, 19.0, 17.6, 16.7, 15.9. HRMS (ESI) m/z for C36H62NO6 ([M+H]+) 604.4575, calc. 604.4572.

28-N-Methoxyaminooleanane-2-deoxy-d-riboside (8r)

White solid (33.9 mg, 58%). 1H-NMR (500 MHz, C5D5N) δ 5.30 (d, J = 3.3 Hz, 0.8H, αH1′), 5.25 (s, 1H), 4.70–4.52 (m, 1H), 4.47–4.34 (m, 1H), 4.28 (d, J = 10.5 Hz, 0.2H), 4.26–4.07 (m, 3H), 3.66 (d, J = 10.0 Hz, 3H), 3.50–3.44 (m, 2H), 1.30 (s, 3H), 1.28 (d, J = 3.5 Hz, 3H), 1.27 (s, 3H), 1.08 (s, 3H), 0.98 (d, J = 6.0 Hz, 3H), 0.97 (t, J = 3.0 Hz, 3H), 0.95 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 145.6, 123.4, 98.5, 93.5, 88.3, 78.7, 72.8, 72.1, 68.9, 68.9, 67.2, 62.6, 61.7, 60.3, 56.3, 48.6, 47.7, 47.2, 46.0, 45.6, 42.5, 40.9, 39.99, 39.72, 37.8, 36.8, 34.0, 31.6, 31.0, 29.3, 28.7, 27.0, 26.8, 26.7, 24.5, 24.4, 24.4, 19.4, 17.8, 17.1, 16.4. HRMS (ESI) m/z for C36H62NO5 ([M+H]+) 588.4616, calc. 588.4623.

Oleanolic acid-28-O-β-d-glucopyranoside (1a)

White solid (75.2 mg, 28%). 1H-NMR (500 MHz, C5D5N) δ 6.34 (d, J = 8.0 Hz, 1H), 5.46 (s, 1H), 4.48–4.03 (m, 6H), 3.44 (dd, J = 10.9, 5.1 Hz, 1H), 3.22 (dd, J = 14.1, 4.4 Hz, 1H), 1.25 (s, 3H), 1.23 (s, 3H), 1.14 (s, 3H), 1.03 (s, 3H), 0.93 (s, 3H), 0.90 (s, 3H), 0.88 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 176.5, 144.2, 123.0, 95.8, 79.4, 78.9, 78.1, 75.7, 74.2, 62.3, 55.8, 48.2, 47.1, 46.3, 42.2, 41.8, 39.9, 39.4, 39.0, 37.4, 34.0, 33.2, 33.2, 32.6, 31.0, 29.1, 28.8, 28.3, 28.1, 26.1, 23.9, 23.5, 18.9, 17.6, 16.6, 15.7 HRMS (ESI) m/z for C36H58O8Na ([M+Na]+) 641.4029, calc. 641.4024.

Erythrodiol-28-O-β-d-glucopyranoside (1b)

White solid (62.8 mg, 23%). 1H-NMR (500 MHz, C5D5N) δ 5.24 (s, 1H), 4.92 (d, J = 7.7 Hz, 1H), 4.62 (d, J = 11.7 Hz, 1H), 4.48 (dd, J = 11.2, 4.4 Hz, 1H), 4.35–4.28 (m, 2H), 4.10 (dd, J = 17.3, 8.2 Hz, 2H), 3.86 (s, 2H), 3.51–3.41 (m, 1H), 1.26 (s, 6H), 1.08 (s, 3H), 1.02 (s, 3H), 0.97 (s, 3H), 0.92 (s, 3H), 0.88 (s, 3H). 13C-NMR (125 MHz, C5D5N) δ 144.7, 122.8, 105.9, 78.8, 78.6, 78.1, 77.2, 75.4, 71.8, 63.0, 55.8, 48.1, 46.7, 43.2, 42.0, 40.2, 39.5, 39.2, 37.3, 37.2, 34.5, 33.5, 32.9, 32.7, 31.2, 28.8, 28.2, 28.2, 26.3, 23.9, 23.9, 22.1, 18.9, 17.1, 16.6, 15.9. HRMS (ESI) m/z for C36H60O7Na ([M+Na]+) 627.4231, calc. 627.4231.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A